0000000000586811

AUTHOR

Laura Cardeñoso

showing 4 related works from this author

Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease

1998

Human cytomegalovirus (HCMV)-specific antibody responses in HIV-1 infected individuals either with or without HCMV end-organ disease were examined to determine the whether development of HCMV disease was associated with a particular deficit in the antibody response. Antiwhole HCMV, anti-glycoprotein B (gB), and neutralizing antibody levels were higher in HIV-1 infected individuals than in healthy immunocompetent subjects, particularly in patients with AIDS either with or without HCMV-associated disease. Irrespective of location and spread of HCMV disease, patients who had received anti-HCMV therapy prior to sampling exhibited significantly higher anti-gB and neutralizing antibody titers tha…

AdultMaleHuman cytomegalovirusAdolescentvirusesCytomegalovirusBiologyAntibodies ViralAntiviral AgentsViral Envelope ProteinsNeutralization TestsBetaherpesvirinaeVirologyImmunopathologymedicineHumansViremiaFluorescent Antibody Technique IndirectNeutralizing antibodyAcquired Immunodeficiency SyndromeAIDS-Related Opportunistic InfectionsAntibody titervirus diseasesbiochemical phenomena metabolism and nutritionmedicine.diseasebiology.organism_classificationVirologyCD4 Lymphocyte CountInfectious DiseasesImmunoglobulin GCytomegalovirus InfectionsImmunologyHIV-1biology.proteinFemaleViral diseaseAntibodyViral loadJournal of Medical Virology
researchProduct

Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytom…

2001

Serum neutralizing and glycoprotein B (gB)-specific antibody levels were monitored prospectively in AIDS patients who either did or did not develop human cytomegalovirus (HCMV) end-organ disease, to delineate further the role of antibodies in protecting against HCMV disease. Antibody levels declined substantially (at least 4-fold) only in patients who developed HCMV disease; this decline in turn occurred concurrently with antigenemia. Nevertheless, AIDS patients who remained free of HCMV disease and did not become antigenemic during the follow-up period maintained stable levels of serum antibodies, with only minor fluctuations. The impact of HAART on the levels of functional anti-HCMV antib…

Human cytomegalovirusbiologybusiness.industryvirusesAntibody titerCongenital cytomegalovirus infectionvirus diseasesmedicine.disease_causemedicine.diseasebiology.organism_classificationVirologyHerpesviridaeInfectious DiseasesBetaherpesvirinaeVirologyImmunopathologyImmunologymedicinebiology.proteinViral diseaseAntibodybusinessJournal of Medical Virology
researchProduct

An Assessment of the Effect of Human Herpesvirus-6 Replication on Active Cytomegalovirus Infection after Allogeneic Stem Cell Transplantation

2010

Human herpesvirus-6 (HHV-6) may enhance cytomegalovirus (CMV) replication in allogeneic stem cell transplant (allo-SCT) recipients either through direct or indirect mechanisms. Definitive evidence supporting this hypothesis are lacking. We investigated the effect of HHV-6 replication on active CMV infection in 68 allo-SCT recipients. Analysis of plasma HHV-6 and CMV DNAemia was performed by real-time PCR. Enumeration of pp65 and IE-1 CMV-specific IFNgamma CD8(+) and CD4(+)T cells was performed by intracellular cytokine staining. HHV-6 DNAemia occurred in 39.8% of patients, and was significantly associated with subsequent CMV DNAemia in univariate (P=.01), but not in multivariate analysis (P…

AdultMaleAdolescentInteractionHerpesvirus 6 Humanmedicine.medical_treatmentvirusesCongenital cytomegalovirus infectionRoseolovirus InfectionsVirus ReplicationYoung AdultHomologous chromosomemedicineHumansTransplantation HomologousCMV replicationAgedImmunosuppression TherapyTransplantationHuman herpesvirus 6 (HHV-6)biologybusiness.industryHematopoietic Stem Cell Transplantationvirus diseasesImmunosuppressionHematologyMiddle Agedmedicine.diseasebiology.organism_classificationAllo-SCT recipientVirologyCMV immune responseTransplantationViral replicationCytomegalovirus InfectionsDNA ViralImmunologyFemaleVirus ActivationHuman herpesvirus 6Stem cellCytomegalovirus (CMV)businessCD8Biology of Blood and Marrow Transplantation
researchProduct

Molecular Surveillance of HIV-1 in Madrid, Spain: a Phylogeographic Analysis ▿

2011

ABSTRACT The molecular epidemiology of HIV-1 is constantly changing, mainly as a result of human migratory flows and the high adaptive ability of the virus. In recent years, Spain has become one of Europe's main destinations for immigrants and one of the western European countries with the highest rates of HIV-positive patients. Using a phylogeographic approach, we have analyzed the relationship between HIV-1 variants detected in immigrant and native populations of the urban area of Madrid. Our project was based on two coincidental facts. First, resistance tests were extended to naïve and newly diagnosed patients, and second, the Spanish government legislated the provision of legal status t…

medicine.medical_specialtyGenotypemedia_common.quotation_subjectImmunologyImmigrationMolecular Sequence DataHuman immunodeficiency virus (HIV)HIV InfectionsBiologyDestinationsmedicine.disease_causeMicrobiologylaw.invention03 medical and health sciences0302 clinical medicinePopulation GroupslawVirologyEpidemiologymedicinePrevalenceCluster AnalysisHumans030212 general & internal medicine030304 developmental biologymedia_commonTransients and Migrants0303 health sciencesMolecular EpidemiologyMolecular epidemiologySequence Analysis DNA3. Good healthPhylogeographyPhylogeographyTransmission (mechanics)Genetic Diversity and EvolutionSpainpol Gene Products Human Immunodeficiency VirusInsect ScienceCohortHIV-1Demography
researchProduct